Skip to main content
Clinical Trials/NCT00597636
NCT00597636
Active, not recruiting
Not Applicable

Genetic Susceptibility to Lung Cancer in Never Smokers

Memorial Sloan Kettering Cancer Center1 site in 1 country238 target enrollmentJune 2005
ConditionsLung Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
238
Locations
1
Primary Endpoint
To evaluate germline genetic variants and their association with lung cancer in never smokers.
Status
Active, not recruiting
Last Updated
10 months ago

Overview

Brief Summary

The purpose of this study is to help us better understand the cellular changes that may lead to the development of lung cancer. We want to compare people who have never smoked and yet have been diagnosed with lung cancer to never smokers who have not developed lung cancer. We hope to use the information obtained in this study as the basis for future studies and will not regard the results from this study as final.

Registry
clinicaltrials.gov
Start Date
June 2005
End Date
June 2026
Last Updated
10 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Cases will be eligible for inclusion if:
  • They have been diagnosed with a lung cancer or have had previous surgical treatment for their lung cancer and have smoked fewer than 100 cigarettes in their lifetime, are/were not regular cigar or pipe smokers, and
  • They have had no prior chemotherapy or radiation treatment within the last year (Exception: genotyping analysis/screening can be performed on specimens from individuals who had chemo/radiation treatment within the last year as germline DNA will not be affected)
  • They speak and read English
  • They understand and agree to sign informed consent, and
  • They agree to give us a blood sample, and
  • They agree to complete the study questionnaire, and
  • They agree to have their pathology information reviewed by study personnel.
  • Controls will be eligible for inclusion if:
  • They have not been diagnosed with any type of cancer, exclusive of nonmelanoma skin cancer and have smoked fewer than 100 cigarettes in their lifetime, are/were not regular cigar or pipe smokers, and

Exclusion Criteria

  • Subjects who do not meet the inclusion criteria for either the case or control groups will not be eligible for this study.
  • All individuals who otherwise meet the eligibility requirements above, but who have had chemotherapy or radiation therapy within 1 year of evaluation will be excluded (Exception: genotyping analysis/screening can be performed on specimens from individuals who had chemo/radiation treatment within the last year as germline DNA will not be affected).

Outcomes

Primary Outcomes

To evaluate germline genetic variants and their association with lung cancer in never smokers.

Time Frame: conclusion of study

Secondary Outcomes

  • To evaluate whether overall DNA damage/repair capacity is associated with lung cancer in never smokers.(conclusion of study)

Study Sites (1)

Loading locations...

Similar Trials